Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (511-520 of 749) with videos related to

Pageof 75
Sort By:
Pancreas|February 13, 2019
Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal AdenocarcinomaEric M Wang, Hironari Akasaka, Jun Zhao, et al.
Journal of Biomedical Informatics|October 21, 2025
Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recordsLiwei Wang, Rui Li, Andrew Wen, et al.
Annals of Surgical Oncology|September 5, 2020
Factors Influencing Exercise Following Pancreatic Tumor ResectionNathan H Parker, Karen Basen-Engquist, M Laura Rubin, et al.
Annals of Surgical Oncology|January 8, 2021
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal AdenocarcinomaMichael G White, Andrew Lee, Diego Vicente, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Discovering Signature Disease Trajectories in Pancreatic Cancer and Soft-tissue Sarcoma from Longitudinal Patient RecordsLiwei Wang, Rui Li, Andrew Wen, et al.
Annals of Surgical Oncology|September 3, 2010
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trialMatthew H G Katz, Nipun B Merchant, Steven Brower, et al.
Annals of Surgical Oncology|December 13, 2018
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic AdenocarcinomaEve Simoneau, Claire Goumard, Jeffrey E Lee, et al.
Journal of Immunological Methods|September 17, 2019
A versatile flow-based assay for immunocyte-mediated cytotoxicityPeter M Rabinovich, Jialing Zhang, Samuel R Kerr, et al.
Romanian Journal of Gastroenterology|July 30, 2002
Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapyManuela G Neuman, Jean-Pierre Benhamou, Asma Ibrahim, et al.
American Journal of Surgery|September 19, 2018
The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinomaJordan M Cloyd, Laura Prakash, Jean-Nicolas Vauthey, et al.
Pageof 75

Showing results (511-520 of 749) with videos related to

Sort By:
Pageof 75
Pancreas|February 13, 2019
Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal AdenocarcinomaEric M Wang, Hironari Akasaka, Jun Zhao, et al.
Journal of Biomedical Informatics|October 21, 2025
Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recordsLiwei Wang, Rui Li, Andrew Wen, et al.
Annals of Surgical Oncology|September 5, 2020
Factors Influencing Exercise Following Pancreatic Tumor ResectionNathan H Parker, Karen Basen-Engquist, M Laura Rubin, et al.
Annals of Surgical Oncology|January 8, 2021
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal AdenocarcinomaMichael G White, Andrew Lee, Diego Vicente, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Discovering Signature Disease Trajectories in Pancreatic Cancer and Soft-tissue Sarcoma from Longitudinal Patient RecordsLiwei Wang, Rui Li, Andrew Wen, et al.
Annals of Surgical Oncology|September 3, 2010
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trialMatthew H G Katz, Nipun B Merchant, Steven Brower, et al.
Annals of Surgical Oncology|December 13, 2018
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic AdenocarcinomaEve Simoneau, Claire Goumard, Jeffrey E Lee, et al.
Journal of Immunological Methods|September 17, 2019
A versatile flow-based assay for immunocyte-mediated cytotoxicityPeter M Rabinovich, Jialing Zhang, Samuel R Kerr, et al.
Romanian Journal of Gastroenterology|July 30, 2002
Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapyManuela G Neuman, Jean-Pierre Benhamou, Asma Ibrahim, et al.
American Journal of Surgery|September 19, 2018
The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinomaJordan M Cloyd, Laura Prakash, Jean-Nicolas Vauthey, et al.
Pageof 75